Shandong Anhong Pharmaceutical

Shandong Anhong Pharmaceutical is a prominent pharmaceutical manufacturing subsidiary of the Qilu Pharmaceutical Group, located in Linyi, Shandong Province, China. The company operates as a major production hub for Active Pharmaceutical Ingredients (APIs) and finished dosage forms, with a strong emphasis on anti-infectives, oncology, and cardiovascular medications. Its state-of-the-art facilities are built to comply with global regulatory standards, including China GMP, US FDA, and EU GMP, enabling the export of essential medicines to international markets. By leveraging Qilu's extensive R&D capabilities, Shandong Anhong focuses on the industrialization of complex chemical drugs and sterile injectable products. The company serves as a vital component of its parent group's vertical integration strategy, ensuring a stable supply of high-quality generic and innovative therapies.